Trends & Analysis
AACR 2026 - Industry Trends, Core Targets & Innovative Therapies
This report analyzes selected AACR 2026 preclinical abstracts to map oncology R&D momentum across targets, indications, and therapeutic modalities. Key signals include continued ADC differentiation, rapid growth of molecular glues and degraders, rising AI-enabled oncology research, and evolving strategies in IO combinations and solid tumor CAR-T. The analysis highlights competitive hotspots such as PD-1/PD-L1, HER2, TROP2, KRAS, PRMT5, EGFR/c-Met, and NSCLC.
Overview
Based on selected AACR 2026 preclinical abstracts, this report provides a concise view of oncology innovation trends, with emphasis on target selection, modality evolution, and translational relevance. It identifies ADCs, PROTACs, molecular glues, bispecific antibodies, and CAR-T as major areas of activity, while AI applications in pathology, biomarker analysis, individualized therapy, and drug discovery emerge as an enabling force. The report also tracks clinical and BD-relevant hotspots, including HER2/TROP2 ADCs, IO combinations, RAS molecular glues, EGFR-TKIs, and solid tumor CAR-T, offering reference value for preclinical oncology strategy and model selection.
Key Insights
Selected AACR 2026 preclinical abstracts covering oncology targets, indications, therapeutic modalities, and translational R&D trends.
- Key innovation areas: ADCs, molecular glues, PROTACs, bispecific antibodies, CAR-T, and IO combination strategies.
- Major focus targets and indications: HER2, TROP2, PD-1/PD-L1, KRAS, PRMT5, EGFR/c-Met; with strong activity in NSCLC, breast cancer, GI cancers, HCC, and melanoma.
- Emerging trend: AI is increasingly applied in pathology, biomarker discovery, individualized therapy, and drug discovery workflows.
- Strategic value: Provides reference insights for target prioritization, preclinical model selection, and oncology BD opportunity assessment.
Unlock Advanced Research Insights with Cyagen’s Resources
Explore an array of valuable resources tailored to enhance your preclinical research. Download mateirals meticulously crafted to provide advanced insights and methodologies. Elevate your research strategies with Cyagen's expertise.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.